Printer Friendly

Browse Biological products industry topic

Product development subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
9 Meters Biopharma presents preclinical data on larazotide. May 18, 2022 228
Mereo BioPharma announces top-line efficacy data from Astraeus Phase 2 trial. Clinical report May 9, 2022 176
Compass Therapeutics Reports Positive Interim Phase 2 Data for ES104 in Combination with Paclitaxel in Biliary Tract Cancers. May 6, 2022 423
Point Biopharma confirms no supply shortages of 177Lu-PNT2002 for SPLASH trial. May 5, 2022 186
ABVC BioPharma begins enrollment for Phase II Part 2 study of ADHD medicine. Clinical report Apr 28, 2022 161
Point Biopharma announces first patient dosed in EU in Phase 3 SPLASH trial. Apr 26, 2022 181
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial. Apr 16, 2022 229
GT Biopharma presents preclinical data at AACR on GTB-5550. Apr 11, 2022 298
Biogen submits final protocol for ADUHELM Phase 4 ENVISION trial to FDA. Mar 30, 2022 242
Sinovac approved for pediatric Covid vaccination in the Philippines. Mar 24, 2022 547
Paradigm Biopharmaceuticals Initiates a Phase 3 Clinical Trial in Knee Osteoarthritis Across the US. Mar 17, 2022 524
Supporting COVID vaccine seed preparation for pre-clinical trial. Mar 16, 2022 290
Supporting COVID vaccine seed preparation for pre-clinical trial. Mar 16, 2022 285
Biogen announces long-term phase 3 data on ADUHELM. Mar 16, 2022 263
Eucure Biopharma doses first patient in phase one multi-regional clinical trial of YH002 in combination with YH001 in Australia. Mar 9, 2022 156
Eucure Biopharma doses first patient in phase one multi-regional clinical trial of YH002 in combination with YH001 in Australia. Mar 9, 2022 155
Elpiscience Receives China Clearance of IND Application for Anti-CD39 Monoclonal Antibody ES002. Feb 11, 2022 220
Covaxin now a universal COVID vaccine for adults, children: Bharat Biotech. Jan 29, 2022 311
Arcturus reports neutralizing antibody immune response to the SARS-CoV-2 Omicron variant from ARCT-154 and ARCT-165 booster clinical trial. Jan 26, 2022 256
Arcturus reports neutralizing antibody immune response to the SARS-CoV-2 Omicron variant from ARCT-154 and ARCT-165 booster clinical trial. Jan 26, 2022 255
Pfizer-BioNTech begin Omicron vaccine trial. Jan 26, 2022 436
Elpiscience Announces First Patient Dosed in US Phase I Clinical Trial of Anti-CD39 Monoclonal Antibody ES002 for Treatment of Advanced Solid Tumors. Jan 20, 2022 255
Sutro Biopharma announces STRO-002 Phase 1 Study interim data for advanced ovarian cancer patients. Jan 6, 2022 203
Sutro Biopharma announces STRO-002 Phase 1 Study interim data for advanced ovarian cancer patients. Jan 6, 2022 204
CanSinoBIO's COVID-19 vaccine found 57.5% effective in Phase III trial. Dec 24, 2021 258
CanSinoBIO's COVID-19 vaccine found 57.5% effective in Phase III trial. Dec 24, 2021 257
First School-Age Participants Enrolled in BPZE1 Pertussis Vaccine Phase 2b SUPER Clinical Trial. Dec 21, 2021 592
Transgene, NEC Tout Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine. Nov 23, 2021 1363
Positive results shown for vTv type 1 diabetes drug. Nov 22, 2021 995
4 vaccine makers submit EUA application for COVID-19 vaccine booster shot---PH FDA. Nov 3, 2021 529
Landos Biopharma announces FDA clearance of IND for LABP-105 for RA. Nov 2, 2021 217
Landos Biopharma announces first subject dosed in Phase 1 study of LABP-104. Oct 28, 2021 218
Gilead and Merck to begin Phase 2 clinical study of islatravir and lenacapavir. Oct 26, 2021 170
Matinas BioPharma initiates dosing in Phase 1 study of MAT2501. Oct 21, 2021 300
Medigen's Phase II MVC-COV1901 vaccine data published in The Lancet Respiratory Medicine. Oct 15, 2021 257
Medigen's Phase II MVC-COV1901 vaccine data published in The Lancet Respiratory Medicine. Oct 15, 2021 258
First Wave BioPharma doses first patient in Phase 2b trial of niclosamide. Oct 14, 2021 292
Africa sets sights on innovative mRNA jab to help meet vaccine gap. Oct 13, 2021 716
Kiromic BioPharma Forges Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers. Oct 13, 2021 444
Landos Biopharma announces FDA clearance of IND for LABP-104. Oct 11, 2021 281
Geron reports publication of IMbark Phase 2 data in Annals of Hematology. Oct 11, 2021 256
Kinnate Biopharma details two-part Phase 1 trial design for KIN-2787. Oct 7, 2021 310
8 applications for COVID-19 vaccine clinical trials so far approved - DOST. Oct 5, 2021 522
RedHill Biopharma announces more data on opaganib global Phase 2/3 study. Clinical report Oct 4, 2021 446
Dynavax, US DOD announce collaboration to develop plague vaccine. Oct 4, 2021 295
Enteris BioPharma announces completion of Phase 1 trial of Peptelligence. Oct 4, 2021 221
Study: Biovanta treats inflammation safely and effectively. Oct 4, 2021 543
Scopus BioPharma's Duet Therapeutic to present preclinical data. Sep 29, 2021 236
VBI Vaccines Posts New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern. Clinical report Sep 29, 2021 385
First Wave BioPharma begins patient screening for Phase 2b trial of niclosamide. Clinical report Sep 28, 2021 237
Impel's Trudhesa spray approved for acute migraines. Sep 20, 2021 855
Three things to know about the Semglee biosimilar. McGowan, Sean Sep 20, 2021 982
Semglee's success may be limited. Sep 20, 2021 593
FDA seeks further data on teplizumab from Provention. Sep 20, 2021 800
RedHill Biopharma announces preliminary data from Phase 2/3 study with opaganib. Sep 14, 2021 200
Kinnate Biopharma presents preclinical data on FGFR inhibitor candidate KIN-3248. Sep 13, 2021 262
AzurRx BioPharma activates trial sites in India for Phase 2 RESERVOIR trial. Clinical report Sep 10, 2021 200
Benitec Biopharma provides overview of BB-301 1b/2a clinical trial design. Clinical report Sep 8, 2021 265
LATEST COMPANY NEWS. Aug 25, 2021 15928
Kadmon says belumosudil 200 mg once daily QD tablets available in U.S. Aug 19, 2021 235
Moderna considers including Australian children in Covid-19 vaccine trial. Aug 13, 2021 349
NRx begins Phase 2b trial of Israel's BriLife Vaccine for COVID-19 in the Nation of Georgia. Aug 10, 2021 254
NRx begins Phase 2b trial of Israel's BriLife Vaccine for COVID-19 in the Nation of Georgia. Aug 10, 2021 255
Don't limit innovation; it's the only route to a healthier world. O'Brien, John Aug 9, 2021 766
Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine. Aug 6, 2021 580
Biogen announces results from Phase 3b NOVA study evaluating natalizumab. Aug 2, 2021 359
Biogen, Eisai announce trial design for ICARE AD-US trial. Clinical report Jul 29, 2021 294
ARCA Biopharma announce paper on Genecaro Phase 2b results. Jul 28, 2021 217
Infinity Pharmaceuticals gives updated data from Phase 2 MARIO-275 trial for UC. Clinical report Jul 27, 2021 386
Landos Biopharma to present Phase 3 data of omilancor in UC at UEGW. Jul 22, 2021 280
Meissa to release positive preclinical data of Intranasal COVID-19 at ASV 2021 on 22 July 2021. Jul 20, 2021 238
Meissa to release positive preclinical data of Intranasal COVID-19 at ASV 2021 on 22 July 2021. Jul 20, 2021 237
Meissa Posts Preclinical Data on Intranasal COVID-19 Vaccine Showing Protection from SARS-CoV-2 Challenge after a Single Dose. Jul 20, 2021 474
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 155
Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. Jul 14, 2021 156
ARCA Biopharma provides update on ASPEN-COVID-19 Phase 2b clinical trial. Jul 13, 2021 269
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 258
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 257
FDA: Sinovac seeks to expand use of its COVID-19 vaccine on children ages 3 to 17. Jul 7, 2021 540
LATEST COMPANY NEWS. Jul 7, 2021 22907
Priority given to vaccine production, science application in health sector. Jul 6, 2021 379
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 270
Clover Biopharmaceuticals completes enrollment of adult and elderly participants under its global pivotal Phase 2/3 clinical trial of its COVID-19 vaccine candidate, SCB-2019. Jul 6, 2021 271
New Alzheimer's drug welcomed. Jul 5, 2021 1463
HDT Bio Receives Notice to Proceed from FDA for US Phase 1 Clinical Trial of RNA COVID-19 Vaccine. Jul 1, 2021 430
VBI Vaccines Touts Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19. Jun 29, 2021 400
Gilead submits NDA to FDA for lenacapavir. Jun 28, 2021 162
Seven and Eight Biopharmaceuticals Inc. Announces the First Patient Treated in a First-in-Human Clinical Trial of the TLR7/8 Dual Agonist BDB018 in Advanced Solid Tumors. Jun 23, 2021 271
RedHill Biopharma announces presentation of oral opaganib phase 2 data. Clinical report Jun 21, 2021 367
Sage Therapeutics, Biogen Post Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder. Financial report Jun 17, 2021 996
Geron says IMbark Phase 2 data published in Journal of Clinical Oncology. Clinical report Jun 17, 2021 231
Landos Biopharma announce outcome of End-of-Phase 2 meeting with FDA. Jun 14, 2021 212
Orgenesis says enrollment is underway for a Phase 2 rotator cuff repair study of its Tissue Genesis Icellator. Jun 11, 2021 362
Biogen's hefty price tag for new drug forecast to spark Alzheimer's research resurgence. Jun 10, 2021 539
Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. Jun 10, 2021 287
Texas Children's Hospital, Baylor College & Biological E. Limited enter Phase III Trials in India for "People's COVId-19 Vaccine" for the underserved nations. Jun 10, 2021 288
RedHill Biopharma completes enrollment of oral opaganib phase 2/3 COVID-19 study. Clinical report Jun 7, 2021 213
Incyte, MorphoSys announce three-year results from Phase 2 L-MIND study. Jun 4, 2021 222
Kinnate Biopharma presents preclinical data from KIN-2787. Jun 4, 2021 233
Achilles Therapeutics presents phase I/IIa clinical trial design of CHIRON. Jun 4, 2021 190
Can-Fite BioPharma to initiate phase IIb NASH study on Namodenoson. Jun 2, 2021 212
Biogen, Bio-Thera announce results from Phase 3 study of BAT1806. Jun 1, 2021 198
Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. May 25, 2021 209
Mexico to commence phase three trials of Sanofi and Walvax's COVID-19 vaccines. May 25, 2021 208
AzurRx BioPharma announces interim data from phase 2 trial of MS1819. May 13, 2021 242
First Patient Dosed in FIREFLY-1 Pivotal Phase 2 Clinical Trial of DAY101 in Pediatric Progressive Low-Grade Glioma. May 12, 2021 895
GT Biopharma provides update on Phase 2 TriKE product candidate trial. May 12, 2021 229
Qpex Biopharma Initiates Phase 1 Study of ORAvance for Oral Treatment of Drug-Resistant Gram-Negative Bacterial Infections. Drug overview May 12, 2021 448
Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. May 10, 2021 195
Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. May 10, 2021 193
Lytix Biopharma reports positive phase I data from LTX-315 cancer trial. May 10, 2021 194
Cue Biopharma announces interim clinical data on phase 1 study of CUE-101. May 10, 2021 203
FDA approves Orgenesis IDE for pilot clinical trial of Tissue Genesis Icellator2. May 6, 2021 184
First Healthy Volunteers Dosed in Phase I/II Trials of Unique COVID-19 RNA Vaccine in India. May 4, 2021 408
Covid-19 vaccine trial plea for young people. Apr 28, 2021 266
New trial to explore how plant-derived Covid vaccine could work. Apr 20, 2021 411
Wales to take part in UK trial for plant-derived Covid-19 vaccine; The vaccine has already been through early phase human studies and now requires testing on a large scale. By, Mark Smith Apr 19, 2021 673
MVP eyes stake in vaccine project, says Glovax CEO. Apr 19, 2021 857
First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis. Apr 15, 2021 422
VBI Vaccines Releases Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic Candidate. Apr 13, 2021 374
China approves new COVID-19 vaccine for clinical trials. Apr 12, 2021 173
Korean firm sets PH vaccine clinical trial. Apr 9, 2021 715
Intravacc reports encouraging preclinical data for SARS-CoV-2 nose spray vaccine, with significant advantages over injectables. Apr 7, 2021 221
Valneva gives UK vaccine progamme another boost with strong trial result. Apr 7, 2021 424
Intravacc reports encouraging preclinical data for SARS-CoV-2 nose spray vaccine, with significant advantages over injectables. Apr 7, 2021 220
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover. Apr 6, 2021 532
Novavax commences crossover arms in two COVID-19 vaccine clinical trials. Apr 6, 2021 159
Novavax commences crossover arms in two COVID-19 vaccine clinical trials. Apr 6, 2021 158
AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide. Apr 6, 2021 182
Landos Biopharma announces FDA clearance of IND application for Omilancor. Apr 6, 2021 188
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 269
BioPharmaceuticals and AstraZeneca's vaccine well tolerated in AZD1222 US Phase III trial, with no safety concerns. Mar 25, 2021 270
Dynavax doses first patient in Phase 2/3 trial for COVID-19 vaccine candidate. Clinical report Mar 24, 2021 215
AzurRx BioPharma completes enrollment in Phase 2 trial of MS1819. Mar 22, 2021 249
Twist Bioscience releases preclinical data on GLP-1R antibodies. Mar 22, 2021 330
GT Biopharma updates interim results of GTB-3550 clinical trial. Mar 17, 2021 188
Gilead, US Merck to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV. Mar 16, 2021 969
Phase III REMDACTA Trial of Actemra Plus Veklury in Patients with Severe COVID-19 Pneumonia Does Not Meet Primary Endpoint. Clinical report Mar 11, 2021 727
VBI Vaccines Starts Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902. Clinical report Mar 10, 2021 385
Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. Mar 10, 2021 262
Novavax expects results of its Phase 3 COVID-19 vaccine trial in the US and Mexico in April 2021. Mar 10, 2021 261
Indian vaccine maker to start clinical trials in Philippines. Mar 7, 2021 327
Transgene, BioInvent Enroll First Patient in Phase I/IIa Trial of Novel Oncolytic Virus BT-001 in Solid Tumors. Mar 2, 2021 846
PH-SoKor firm offers 40 M doses of COVID vaccines 50 percent cheaper. Mar 1, 2021 963
Garin calls for review of FDA recommendation against Sinovac vaccine. Feb 24, 2021 539
GlaxoSmithKline and Sanofi to push ahead with phase II trial of Covid-19 vaccine. Feb 23, 2021 565
TOP NEWS: Sanofi, GSK Begin Covid Vaccine Candidate Phase Two Study. Feb 22, 2021 201
Vaccine suppliers with EUA may start phase 3 trials. Feb 22, 2021 359
Sinovac Releases Phase III Results of Its COVID-19 Vaccine. Feb 5, 2021 411
Vaccine developers to be held responsible for clinical trial injury -- Dela Pena. Feb 4, 2021 375
RedHill Biopharma receives unanimous support from DSMB for global Phase 2/3 trial of opaganib. Feb 2, 2021 556
RedHill Biopharma receives unanimous support from DSMB for global Phase 2/3 trial of opaganib. Feb 2, 2021 554
China's CanSino to advance Phase III trials of its COVID-19 vaccine candidate. Feb 1, 2021 170
China's CanSino to advance Phase III trials of its COVID-19 vaccine candidate. Feb 1, 2021 166
Clover partners with Dynavax for planned Global Phase 2/3 efficacy trial of adjuvanted COVID-19 vaccine candidate. Feb 1, 2021 253
Clover partners with Dynavax for planned Global Phase 2/3 efficacy trial of adjuvanted COVID-19 vaccine candidate. Feb 1, 2021 249
Drug firm to hold Covid vaccine clinical trial in Bacolod City. Jan 28, 2021 299
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 168
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 167
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 163
MorphoSys, I-Mab Dose First Patient In Phase One Study Of Cancer Drug. Jan 26, 2021 223
Phase 1B begins Monday But vaccines at start still expected to be scarce. Jake Griffin jgriffin@dailyherald.com Jan 23, 2021 929
Phase 1B begins Monday But vaccines at start still expected to be scarce Phase: Counties now taking or will take registrations via websites. Jake Griffin jgriffin@dailyherald.com Jan 23, 2021 929
Next phase of vaccinations begins Monday, but state warns shots are still scarce. Jake Griffin jgriffin@dailyherald.com Jan 23, 2021 934
LIST: Target trial sites in PH for Janssen, Clover, Sinovac vaccines. Jan 22, 2021 356
Technology Fully Tapped in the Race for the Much-awaited Vaccine. Jan 21, 2021 544
Sinovac use eyed in 'specific sector' during PH clinical trials --- DOH. Jan 20, 2021 397
Duterte to senators: You want Pfizer? We'll order for you. Jan 19, 2021 503
Transgene, BioInvent Receive Approval from ANSM to Proceed with Phase I/IIa Trial of Anti-CTLA4-armed Oncolytic Virus BT-001 in Solid Tumors. Jan 19, 2021 836
Dr. Reddy's Laboratories to begin phase 3 study of Sputnik V vaccine in India. Jan 18, 2021 230
Dr. Reddy's Laboratories to begin phase 3 study of Sputnik V vaccine in India. Jan 18, 2021 231
Janssen, Clover pushing through with Philippine trials. Jan 15, 2021 649
Vaccine Publishes Results from a Phase 4 Study of VBI Vaccines' Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine. Jan 15, 2021 553
Poe urges faster processing of emergency use authority applications from vaccine makers. Jan 11, 2021 636
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 224
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 223
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 219
Indian vaccine maker denies trial 'irregularities'. Sanjay Kumar Jan 9, 2021 766
RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. Jan 8, 2021 476
FDA okays Chinese firm's vaccine clinical trials. Jan 8, 2021 263
China's Clover gets nod for Philippine trials. Jan 8, 2021 400
RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. Jan 8, 2021 474
Icon Supports Pfizer, BioNTech on the Investigational COVID-19 Vaccine Trial. Jan 5, 2021 314
RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. Clinical report Jan 4, 2021 316
RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. Clinical report Jan 4, 2021 312
China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. Dec 30, 2020 221
China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. Dec 30, 2020 225
As vaccines are rolled out, questions remain. Dec 27, 2020 734
Analyzing the Facts-ination: #WhenwillwebeaVaccineNation? Dec 26, 2020 964
Korea shows little progress in vaccine development. Dec 23, 2020 629
Transgene and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT-001 in Solid Tumors. Dec 22, 2020 561
COVID-19: Australia cancels order for vaccine as trial stumbles. Dec 21, 2020 429
France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. Dec 16, 2020 248
France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. Dec 16, 2020 252
Tests to start for new vaccine; CLINICAL TRIALS TO BEGIN IN NEWCASTLE. KATIE DICKINSON Reporter katie.dickinson@ncjmedia.co.uk Dec 16, 2020 333
First Subject Dosed in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China. Dec 11, 2020 1179
No more Philippine clinical trials for AstraZeneca. Dec 11, 2020 778
Oxford/Astra first to publish final-stage vaccine trial results. Dec 9, 2020 674
Clover Biopharmaceuticals Touts Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates. Dec 7, 2020 511
DOST: Trials for China's Sinovac, Clover may start end-2020 or early 2021. Nov 27, 2020 380
VBI Vaccines Touts Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection. Nov 19, 2020 505
2nd vaccine 94.5% effective, trial shows. MARTIN BAGOT Nov 17, 2020 180
UK to lead final trials of vaccine. Nov 16, 2020 215
6,000 UK participants sought for final-stage Covid-19 vaccine trials. Nov 16, 2020 241
6,000 volunteers needed for final stage test of Covid vaccine; So far around 25,000 people in the UK have participated in vaccine trials. By, Neil Shaw Nov 16, 2020 636
Johnson & Johnson Seeks 6,000 UK Participants For Vaccine Trial. Nov 16, 2020 641
Medicago and GSK to begin final Covid-19 vaccine trials. Nov 13, 2020 333
Brazil allows trials of Chinese vaccine to resume. Nov 12, 2020 511
China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. Nov 10, 2020 217
China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. Nov 10, 2020 221
Brazil halts trials of Chinese Covid-19 vaccine. Nov 10, 2020 574
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 277
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 281
Dr. Reddy's Partners On Sputnik V vaccine Clinical Trials in India. Oct 29, 2020 345
Precision NanoSystems Will Receive CDN 18.2m from the government of Canada to Develop an RNA Vaccine for COVID-19. Oct 26, 2020 299
Cyclacel Pharmaceuticals presents Phase 1 data on fadraciclib. Oct 26, 2020 330
RedHill Biopharma presents new data from Talicia Phase 3 studies. Oct 26, 2020 367
US gives full approval to antiviral remdesivir to treat Covid-19. Oct 23, 2020 542
Merck Touts Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine. Oct 22, 2020 906
Trump gets Gilead drug, Regeneron antibody mix. Oct 19, 2020 841
Mereo BioPharma announces FDA clearance for Phase 1b/2 study of etigilimab. Oct 19, 2020 198
'Change of mind:' China-based pharma firm will not join vaccine trials. Oct 17, 2020 305
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 161
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 165
China's Sinovac hurdles initial stage of screening for clinical trials in Philippines. Oct 15, 2020 307
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 507
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 505
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis. Oct 13, 2020 387
Gilead, Galapagos presents data from Phase 2b/3 trial of filgotinib. Oct 12, 2020 563
3 int'l COVID-19 vaccine makers gunning for Phase 3 clinical trials in PH. Oct 8, 2020 354
ARCA Biopharma announces FDA approval of IND application for AB201. Oct 7, 2020 342
IDMC recommends Can-Fite BioPharma continue Comfort trial, discontinue Acrobat. Oct 6, 2020 273
GSK ready with Theraflu portfolio. Oct 5, 2020 734
CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. Sep 30, 2020 179
CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. Sep 30, 2020 175
COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. Sep 29, 2020 253
COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. Sep 29, 2020 249
Egypt's health minister takes part in clinical trial of Chinese coronavirus vaccine candidate. Egypt Today staff Sep 28, 2020 341
India's vaccine capacity will help 'all humanity' - Modi. Sep 27, 2020 688
Clover Biopharmaceuticals Touts Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate. Sep 25, 2020 683
Spend 94 billion won this year to develop homegrown COVID-19 vaccine. Sep 25, 2020 296
UK: Another COVID-19 vaccine enters final stage trials. Sep 25, 2020 234
Sinovac's Coronavac, SARS-CoV-2 Vaccine, Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children. Sep 24, 2020 307
Sinovac Starts Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey. Sep 22, 2020 485
Seattle Genetics, Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020. Sep 21, 2020 570
Seattle Genetics, Genmab presents data from innovaTV 204 phase 2 trial. Sep 21, 2020 482
Genentech presents new data from multiple Phase III studies of Tecentriq in TNBC. Sep 20, 2020 452
Astellas Pharma, Seattle Genetics announce Padcev trial meets primary endpoint. Sep 18, 2020 216
I-MAB, MorphoSys announce FDA clearance of IND for MOR210/TJ210. Sep 17, 2020 195
Bahrain crown prince volunteers in Covid-19 vaccine trial. Arab News Sep 16, 2020 218
Phase 3 Testing: Is The Vaccine Safe? Claudia Z Sep 15, 2020 600
Vaxart announces FDA clearance of IND application for oral COVID-19 vaccine. Sep 14, 2020 181
AstraZeneca, Oxford University Resume Covid-19 Vaccine Trials In UK. Sep 14, 2020 267
7 firms sign CDA for vaccine trial candidates. Sep 10, 2020 387
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness of participant. ANI Sep 9, 2020 563
Genentech initiates Phase III clinical trial programs for fenebrutinib, Ocrevus. Sep 9, 2020 539
Sutro Biopharma reports Phase 1 data of STRO-002 in ovarian cancer. Sep 9, 2020 240
Strongbridge Biopharma announces 'positive' results from Phase 3 RECORLEV study. Clinical report Sep 8, 2020 171
Strongbridge Biopharma expects to submit RECORLEV NDA in 1Q21. Clinical report Sep 8, 2020 172
South Korea to spend W171 billion to develop COVID-19 vaccine. Sep 4, 2020 265
Florence Healthcare Supports Pfizer's COVID-19 Vaccine Clinical Trials with Extensive Connectivity Platform. Sep 3, 2020 263
Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial. Sep 3, 2020 188
TAKE YOUR BEST SHOT: The whole world wants a vaccine, but countries will naturally try to secure a supply for themselves first. Regalado, Antonio Sep 1, 2020 2302
Taiwan approves human trials for 2nd coronavirus vaccine. Aug 28, 2020 245
Scancell Holdings consortium gets government backing for Covid trial. Aug 28, 2020 283
Taiwan's 1st coronavirus vaccine on track for Phase II trials in Nov. Aug 27, 2020 343
BeiGene to develop, manufacture Singlomics anti-COVID-19 antibodies. Clinical report Aug 27, 2020 215
Mereo BioPharma initiates Phase 1b/2 trial with alvelestat in COVID-19. Aug 25, 2020 289
Matinas BioPharma publishes data from Phase 1 EnACT study of MAT2203 to treat cryptococcal meningitis. Aug 21, 2020 450
Taiwan's 1st coronavirus vaccine approved for human trials. Aug 18, 2020 327
A shot for humanity: UAE's vaccine trial for Covid-19. Reach by Gulf News Aug 14, 2020 1056
PH in talks with 16 other vaccine developers for COVID-19, not just Russia -- DOH. Aug 14, 2020 869
A shot for humanity: Join UAE's vaccine trial for Covid-19. Reach by Gulf News Aug 13, 2020 977
PH panel meets with Russian vaccine manufacturer to discuss clinical trials. Aug 12, 2020 375
DOST to meet Russian vaccine maker on possible PH participation in clinical trials. Aug 12, 2020 484
Gilead submits NDA to FDA for Veklury for COVID-19 treatment. Clinical report Aug 10, 2020 224
US conducts further clinical trial for remdesivir as COVID-19 treatment. Aug 7, 2020 525
RedHill Biopharma Phase 2/3 COVID-19 study approved in Mexico. Aug 6, 2020 220
Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. Jul 31, 2020 188
Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. Jul 31, 2020 192
RedHill Biopharma initiates global Phase 2/3 study for COVID-19. Jul 30, 2020 196
Genentech Shares Disappointing News on Phase III COVACTA Trial of Actemra in Hospitalized Patients with Severe COVID-19 Associated Pneumonia. Jul 29, 2020 915
Cue Biopharma begins dosing Cohort 5 in Phase 1 trial of CUE--101. Jul 28, 2020 290
Moderna's BARDA agreement expanded to support Phase 3 trial of COVID vaccine. Jul 26, 2020 386
Moderna's BARDA agreement expanded to support larger Phase 3 COVID vaccine trial. Jul 26, 2020 386
Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials. Jul 23, 2020 257
RedHill Biopharma submits CTAs in Brazil, Mexico for Phase 2/3 COVID-19 program. Jul 22, 2020 344
Biogen to initiate Phase 4 study of SPINRAZA in patients treated with Zolgensma. Jul 21, 2020 377
9 Meters Biopharma doses first patients in Phase 1b/2a clinical trial in SBS. Jul 21, 2020 213
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 504
UAE begins world's first phase 3 trial of inactivated Covid vaccine. Jul 16, 2020 1003
RedHill Biopharma receives approval for Phase 2/3 COVID-19 study. Jul 16, 2020 350
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 502
Dynavax announces first patients dosed in Phase 1 trial of Medicago's vaccine. Jul 14, 2020 277
Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile. Jul 13, 2020 546
Biogen initiates new phase 3 study of BAN2401 in preclinical AD. Jul 13, 2020 184
Genentech Says New Data from Phase IIIb Study Reinforces Safety Profile of Hemlibra in People with Hemophilia A. Jul 13, 2020 681
DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. Jul 10, 2020 761
DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. Jul 9, 2020 681
Brazil to become testing ground for coronavirus vaccine. Jul 8, 2020 732

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |